Publication | Open Access
Inhibition of dextran sulphate sodium (DSS)-induced colitis in mice by intracolonically administered antibodies against adhesion molecules (endothelial leucocyte adhesion molecule-1 (ELAM-1) or intercellular adhesion molecule-1 (ICAM-1))
158
Citations
20
References
1999
Year
InflammationChronic Inflammatory DiseasesAnti-inflammatoryDextran Sulphate SodiumAutoimmune DiseaseImmunologyImmune RegulationPathologyChronic InflammationAdhesion MoleculesAutoimmunityIntracolonic AdministrationDss-induced ColitisUlcerative ColitisImmunotherapyMedicineIntercellular Adhesion Molecule-1
We examined the effect of intracolonic administration of anti-adhesion molecule antibodies on DSS-induced colitis in mice. Immunohistochemical staining in mice with colitis showed increased expression of ELAM-1 and ICAM-1 on endothelial cells of vessels in the lamina propria and submucosa at sites of inflamed lesions. Intracolonic administration of anti-ELAM-1 or anti-ICAM-1 antibody decreased bloody stools, anaemia, and histologically evident damage, as well as myeloperoxidase activity and IL-1beta content. We concluded that adhesion molecule expression is important in the development of DSS-induced colitis in mice and that intracolonic administration of anti-adhesion molecule antibodies, especially anti-ELAM-1 antibody, effectively inhibits the colonic inflammation. Intracolonic administration of anti-adhesion molecule antibodies may show therapeutic promise in ulcerative colitis.
| Year | Citations | |
|---|---|---|
Page 1
Page 1